FDA Approved: CILOSTAZOL — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Cilostazol submitted by Teva Pharmaceuticals USA, Inc. This action updates the regulatory status of the product unde…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intermittent Claudication
• Peripheral Artery Disease

Drugs mentioned

• Cilostazol (Cilostazol)

Snippet

SUPPL AP for CILOSTAZOL (CILOSTAZOL)